Skip to main content
Top
Published in: Medical Oncology 3/2010

01-09-2010 | Original paper

Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B

Authors: Alessandro Allegra, Giuseppa Penna, Andrea Alonci, Angela Granata, Arianna D’Angelo, Caterina Musolino

Published in: Medical Oncology | Issue 3/2010

Login to get access

Abstract

Immune thrombocytopenia is a disease mediated by platelet autoantibodies that accelerate platelet destruction and inhibit their production. Most cases are considered idiopathic, whereas others are secondary to coexisting conditions such as infectious diseases. All hepatotropic viruses seem able to cause thrombocytopenia. The advent of molecular techniques has revealed the possible persistence of hepatitis B virus genome in HBsAg-negative individuals with or without serologic markers of previous infection. This form of infection is named occult. We report a case of autoimmune thrombocytopenia associated with acute reverse seroconversion of hepatitis B in a patient who was initially hepatitis B virus surface antigen negative and hepatitis B virus surface antibody positive. The search for occult HBV infection before immunosuppressive therapy and monitoring for reactivation is today diagnostic standard and several reports have been presented in literature about HBV reactivation following immunosuppressive therapy. In our patient, reactivation of dormant HBV happened prior to any immunosuppressive therapy. The case we report offers the occasion to emphasize the importance of medium-term and long-term hemovigilance also in other kind of patients than in subjects on immunosuppressive therapy. A deeper follow-up is advisable even in patients showing an unexplainable worsening of their hematological conditions.
Literature
1.
go back to reference Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;113:6511–21.CrossRefPubMed Cines DB, Bussel JB, Liebman HA, Luning Prak ET. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;113:6511–21.CrossRefPubMed
2.
go back to reference Michalska Z, et al. Autoimmune reactions in HBV and HCV. Med Sci Monit. 2001;7(Suppl 1):175–80.PubMed Michalska Z, et al. Autoimmune reactions in HBV and HCV. Med Sci Monit. 2001;7(Suppl 1):175–80.PubMed
3.
go back to reference Douglas B, et al. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;26:6511–21. Douglas B, et al. The ITP syndrome: pathogenic and clinical diversity. Blood. 2009;26:6511–21.
4.
go back to reference Tanir G, Aydemir C, Tuygun N, Kaya O, Yarali N. Immune thrombocytopenic purpura as sole manifestation in a case of acute hepatitis A. Turk J Gastroenterol. 2005;4:217–9. Tanir G, Aydemir C, Tuygun N, Kaya O, Yarali N. Immune thrombocytopenic purpura as sole manifestation in a case of acute hepatitis A. Turk J Gastroenterol. 2005;4:217–9.
5.
go back to reference Thapa R, Mallick D, Ghosh A. Childhood hepatitis E infection complicated by acute immune thrombocytopenia. J Pediatr Hematol Oncol. 2009;31(2):151.CrossRefPubMed Thapa R, Mallick D, Ghosh A. Childhood hepatitis E infection complicated by acute immune thrombocytopenia. J Pediatr Hematol Oncol. 2009;31(2):151.CrossRefPubMed
6.
go back to reference Kim EB et al. Hepatitis B virus reactivation in a surface antigen-negative and antibody-positive patient after rituximab plus CHOP chemotherapy. Cancer Res Treat. 2008; 40:1, 36. Kim EB et al. Hepatitis B virus reactivation in a surface antigen-negative and antibody-positive patient after rituximab plus CHOP chemotherapy. Cancer Res Treat. 2008; 40:1, 36.
7.
go back to reference Geier DA, Geier MR. A case–control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity. 2005;38(4):295–301.CrossRefPubMed Geier DA, Geier MR. A case–control study of serious autoimmune adverse events following hepatitis B immunization. Autoimmunity. 2005;38(4):295–301.CrossRefPubMed
8.
go back to reference Geier MR, Geier DA. A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the vaccine adverse event reporting system (VAERS) database and literature review. Clin Exp Rheumatol. 2004;22(6):749–55.PubMed Geier MR, Geier DA. A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the vaccine adverse event reporting system (VAERS) database and literature review. Clin Exp Rheumatol. 2004;22(6):749–55.PubMed
9.
go back to reference Raimondo G, Pollicino T, Squadrito G. What is the clinical impact of occult hepatitis B virus infection? The Lancet. 2005;365:638–9. Raimondo G, Pollicino T, Squadrito G. What is the clinical impact of occult hepatitis B virus infection? The Lancet. 2005;365:638–9.
10.
go back to reference Raimondo G, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49:652–7.CrossRefPubMed Raimondo G, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49:652–7.CrossRefPubMed
11.
go back to reference Kitano K, et al. Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region. Eur J Haematol. 2006;77:255–8.CrossRefPubMed Kitano K, et al. Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region. Eur J Haematol. 2006;77:255–8.CrossRefPubMed
12.
go back to reference Raimondo G, et al. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol. 2008;48:743–6.CrossRefPubMed Raimondo G, et al. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol. 2008;48:743–6.CrossRefPubMed
13.
go back to reference Aubourg A, d’Alteroche L, Senecal D, Gaudy C, Bacq Y. Autoimmune thrombopenia associated with hepatitis B reactivation (reverse seroconversion) after autologous hematopoietic stem cell transplantation. Gastroenterol Clin Biol. 2007;31(1):97–99. Aubourg A, d’Alteroche L, Senecal D, Gaudy C, Bacq Y. Autoimmune thrombopenia associated with hepatitis B reactivation (reverse seroconversion) after autologous hematopoietic stem cell transplantation. Gastroenterol Clin Biol. 2007;31(1):97–99.
14.
go back to reference Lubel JS, Testro AG, Angus PW. Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management. Int Med Journal. 2007;37:705–12. Lubel JS, Testro AG, Angus PW. Hepatitis B virus reactivation following immunosuppressive therapy: guidelines for prevention and management. Int Med Journal. 2007;37:705–12.
15.
go back to reference Iannacone M, Sitia G, Ruggeri ZM, Guidot LG. HBV pathogenesis in animal models: recent advances on the role of platelets. J Hepatol. 2007;46(4):719–26.CrossRefPubMed Iannacone M, Sitia G, Ruggeri ZM, Guidot LG. HBV pathogenesis in animal models: recent advances on the role of platelets. J Hepatol. 2007;46(4):719–26.CrossRefPubMed
Metadata
Title
Exacerbation of chronic idiopathic thrombocytopenic purpura following reactivation of an occult hepatitis B
Authors
Alessandro Allegra
Giuseppa Penna
Andrea Alonci
Angela Granata
Arianna D’Angelo
Caterina Musolino
Publication date
01-09-2010
Publisher
Springer US
Published in
Medical Oncology / Issue 3/2010
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-009-9305-x

Other articles of this Issue 3/2010

Medical Oncology 3/2010 Go to the issue